
January 24, 2007
Research: Monitoring
advertisement
Question from Longmont, Colorado, USA:
Has the Barbara Davis Center ever evaluated the Glucose-Sensing RFID Microchip designed by the Digital Angel Corporation? If so, is it viable?
Answer:
From: DTeam Staff
As noted in the press release, this product has not yet been developed, and no clinical trials have been conducted.
JSH